TY  - GEN
AU  - Sanai,Faisal M
AU  - Altraif,Ibrahim H
AU  - Alswat,Khalid
AU  - AlZanbagi,Adnan
AU  - Babatin,Mohamed A
AU  - AlMousa,Abdallah
AU  - Almutairi,Nawaf H
AU  - Aljawad,Mohammed S
AU  - Alghamdi,Abdullah S
AU  - Aljumah,Abdulrahman A
AU  - Alalwan,Abduljaleel M
AU  - Al-Hamoudi,Waleed K
AU  - Assiri,Abdullah M
AU  - Dahlan,Yaser
AU  - Alsahafi,Ashwaq
AU  - Alothmani,Hammad S
AU  - AlSaleemi,Mohammed S
AU  - Mousa,Waleed A
AU  - Albenmousa,Ali
AU  - Awny,Abdelrahman
AU  - Albiladi,Haziz
AU  - Abdo,Ayman A
AU  - AlGhamdi,Hamdan
TI  - Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis
SN  - 1532-2742
PY  - 2019///0916
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Cohort Studies
KW  - Female
KW  - Fluorenes
KW  - Genotype
KW  - Hepacivirus
KW  - drug effects
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Liver Cirrhosis
KW  - Male
KW  - Middle Aged
KW  - Ribavirin
KW  - Sofosbuvir
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Uridine Monophosphate
N1  - Publication Type: Journal Article; Observational Study
UR  - https://doi.org/10.1016/j.jinf.2018.04.001
ER  -